Question follow-through · 97926
Vorasidenib
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of the use of the drug Vorasidenib to manage the symptoms and progression of low grade Glioma.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 8 Dec 2025
- Target answer date
- 10 Dec 2025
- Answer
- 15 Dec 2025 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Leukaemia: Diagnosis · 2 Jan 2026
- Breast Cancer: Health Services · 26 Mar 2026
- Brain: Tumours · 28 Aug 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
8 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of the use of the drug Vorasidenib to manage the symptoms and progression of low grade Glioma.
10 Dec 2025
Target answer date
Date supplied by the official written-questions record.
15 Dec 2025
Answer published
While the Department has made no assessment, the National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations for the National Health Service on whether new medicines should be routinely funded...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Leukaemia: Diagnosis
2 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether his Department will commit to publishing regular data on leukaemia diagnosis delays and outcomes.
Breast Cancer: Health Services
26 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve outcomes for invasive lobular breast cancer patients.
Brain: Tumours
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what consideration she has given to the potential impact of the use of Depo-Provera on trends in the level of meningioma.